MISONIX, INC. (NASDAQ:MSON) Files An 8-K Submission of Matters to a Vote of Security Holders
Item5.07
|
Submission of Matters to a Vote of Security Holders. |
At the annual meeting of shareholders of Misonix, Inc. (the
Company) held on June 13, 2017, the shareholders of the Company:
| (i) |
elected John W. Gildea, Charles Miner III, Patrick A. McBrayer, Thomas M. Patton and Stavros G. Vizirgianakis to serve as directors of the Company; |
| (ii) | approved the Misonix, Inc. 2017 Equity Incentive Plan; |
| (iii) |
approved, on a non-binding advisory basis, the compensation of the Companys named executive officers; and |
| (iv) |
ratified the appointment of Grant Thornton LLP as the Companys independent registered public accounting firm for the fiscal year ending June 30, 2017. |
1.The votes cast by shareholders with respect to the election of
directors were as follows:
| Votes | Votes | Broker | ||||
| Director | For | Withheld | Non-Votes | |||
| John W. Gildea | 2,608,702 | 1,061,979 | 2,530,440 | |||
| Charles Miner III | 2,735,576 | 935,105 | 2,530,440 | |||
| Patrick A. McBrayer | 3,281,386 | 389,295 | 2,530,440 | |||
| Thomas M. Patton | 3,152,363 | 518,318 | 2,530,440 | |||
| Stavros G. Vizirgianakis | 3,609,132 | 61,549 | 2,530,440 |
2.The votes cast by the shareholders with respect to the approval
of the Misonix, Inc. 2017 Equity Incentive Plan were as follows:
| Votes For | Votes Against | Abstentions | Broker Non-Votes | |||
| 2,615,202 | 1,045,869 | 9,610 | 2,530,440 |
3.The votes cast by the shareholders with respect to the
approval, on a non-binding advisory basis, of the compensation of
the Companys named executive officers were as follows:
| Votes For | Votes Against | Abstentions | Broker Non-Votes | |||
| 3,562,852 | 92,624 | 15,205 | 2,530,440 |
4.The votes cast by shareholders with respect to the ratification
of the appointment of Grant Thornton LLP as the Companys
independent registered public accounting firm for the fiscal year
ending June 30, 2017 were as follows:
| Votes For | Votes Against | Abstentions | ||
| 5,959,239 | 141,701 | 100,181 |
There were no broker non-votes with respect to this proposal.
About MISONIX, INC. (NASDAQ:MSON)
MISONIX, INC. (Misonix) is a surgical device company. The Company designs, manufactures and markets therapeutic ultrasonic products across the world for spine surgery, skull-based surgery, neurosurgery, wound and burn debridement, cosmetic surgery, laparoscopic surgery and other surgical applications. The Company’s products include BoneScalpel, BoneScalpel MIS System, SonicOne O.R. System and SonaStar. BoneScalpel is an ultrasonic cutting system with applications in orthopedic and reconstructive surgery, as well as neurosurgery. BoneScalpel MIS System offers deep cuts through osseous structures with minimal blood loss. Misonix SonicOne O.R. System is an ultrasonic surgical debridement system that allows surgeons to address the challenges chronic wounds present to them, the patient, and the health-care system. SonaStar is used for neurosurgical procedures, such as skull/non-skull base tumor resections, transnasal procedures and acoustic mengiomas.
